Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: Differentiation between choroidal scars and active lesions

International Ophthalmology

Volumn 33, Issue 5, 2013, Pages 571-577

  Knecht, Pascal B ^a,b   Mantovani, Alessandro ^c   Herbort, Carl P ^a,d  

^a Centre for Ophthalmic Specialized Care (COS)   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c VALDUCE HOSPITAL   (Italy)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Disease activity; Indocyanine green angiography; Uveitis; Vogt Koyanagi Harada disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; MEPREDNISONE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADOLESCENT; ADULT; ARTICLE; ASEPTIC NECROSIS; CASE REPORT; CHOROIDITIS; CONJUNCTIVAL HYPEREMIA; DEPIGMENTATION; EYE DISEASE; FEMALE; HEADACHE; HIP ARTHROPLASTY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE; LASER FLARE PHOTOMETRY; OPTIC DISC HYPEREMIA; OPTIC DISC HYPERFLUORESCENCE; PHOTOMETRY; PLEOCYTOSIS; SCAR FORMATION; UVEITIS; VITRITIS; VOGT KOYANAGI SYNDROME; YOUNG ADULT;

ADOLESCENT; CHOROIDITIS; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INDOCYANINE GREEN; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 84890230286     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-012-9692-4     Document Type: Article

References (25)

1. Wang C, Tian Y, Lei B et al (2012) Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53:4668-4675
2. Yang Y, Xiao X, Li F et al (2012) Increased IL-7 expression in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53:1012-1017
3. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S (2000) Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165:7323-7329 (Pubitemid 32001213)
4. Nussenblatt R, Whitcup S (2010) Uveitis, 4th edn. Mosby Elsevier, Philadelphia
5. Yanoff M, Duker JS (2009) Ophthalmology, 3rd edn. Mosby Elsevier, Philadelphia
6. Bouchenaki N, Herbort CP (2011) Indocyanine green angiography guided management of Vogt-Koyanagi-Harada disease. J Ophthalmic Vis Res 6:241-248
7. Herbort CP, Mantovani A, Bouchenaki N (2007) Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 27:173-182 (Pubitemid 46909258)
8. Inomata H, Sakamoto T (1990) Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res 9(Suppl):35-40 (Pubitemid 20295598)
9. Miyanaga M, Kawaguchi T, Miyata K et al (2010) Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 54:377-382
10. Okada AA, Mizusawa T, Sakai J, Usui M (1998) Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol 82:1175-1181
11. Yuzawa M, Kawamura A, Matsui M (1993) Indocyanine green video-angiographic findings in Harada's disease. Jpn J Ophthalmol 37:456-466 (Pubitemid 24029369)
12. Nakao K, Abematsu N, Mizushima Y, Sakamoto T (2012) Optic disc swelling in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53:1917-1922
13. Suzuki S (1999) Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 43:327-333 (Pubitemid 29329394)
14. Hogan MJ, Kimura SJ, Thygeson P (1959) Signs and symptoms of uveitis I. Anterior uveitis. Am J Ophthalmol 47:155-170
15. Herbort CP, Guex-Crosier Y, de Ancos E, Pittet N (1997) Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 104:64-71; discussion 71-62
16. Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM (2012) The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol 90(8):e603-e608
17. Read RW, Yu F, Accorinti M et al (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142:119-124 (Pubitemid 43964911)
18. Kawaguchi T, Horie S, Bouchenaki N et al (2010) Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 30:41-50
19. Bouchenaki N, Herbort CP (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 108:54-64 (Pubitemid 32059537)
20. Gupta SR, Suhler EB, Rosenbaum JT (2010) Intravenous methylprednisolone can cause an acute, vision-threatening rise in intraocular pressure. J Clin Rheumatol 16:397-398
21. Badsha H, Edwards CJ (2003) Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum 32:370-377 (Pubitemid 36759364)
22. Haugeberg G, Griffiths B, Sokoll KB, Emery P (2004) Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Ann Rheum Dis 63:940-944 (Pubitemid 38961918)
23. Erstad BL (1989) Severe cardiovascular adverse effects in association with acute, high-dose corticosteroid administration. DICP 23:1019-1023 (Pubitemid 20019839)
24. Markomichelakis NN, Halkiadakis I, Papaeythymiou-Orchan S et al (2006) Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm 14:29-33 (Pubitemid 43336316)
25. Bartalena L, Krassas GE, Wiersinga W et al (2012) Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active graves' orbitopathy. J Clin Endocrinol Metab 97(12):4454-4463